TAC Versus TC for Adjuvant Breast Cancer

NCT00493870 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1961

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Docetaxel
DRUG: Doxorubicin
DRUG: Cyclophosphamide

Sponsor

US Oncology Research

Collaborators

[object Object]